In 2025, the sector in ASEAN was valued at USD 21.47 billion, reflecting a year-over-year growth rate of 14.6%.
Forecasts show that, by the end of 2033, the ASEAN Infusion Services Market size is expected to reach USD 86.10 billion, registering a CAGR of 19.0% throughout the projection period.
Private hospital network expansion across Southeast Asia is increasing biologic infusion availability, particularly in urban oncology clusters.
ASEAN health cooperation reports emphasize non-communicable disease growth, supporting structural expansion of systemic therapy capacity in member states.
DataCube Research Report (Feb 2026): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.
*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation.
[Learn more]